NYSE:UNH - UnitedHealth Group Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$262.33 -0.77 (-0.29 %)
(As of 08/17/2018 04:00 PM ET)
Previous Close$262.33
Today's Range$261.72 - $264.13
52-Week Range$186.00 - $264.30
Volume1.92 million shs
Average Volume3.16 million shs
Market Capitalization$250.59 billion
P/E Ratio26.05
Dividend Yield1.38%
Beta0.71
UnitedHealth Group logoUnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals through programs offered by employers, payers, government entities, and directly with the care delivery systems. The OptumInsight segment offers software and information products, advisory consulting arrangements, and services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery and specialty pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

Receive UNH News and Ratings via Email

Sign-up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:UNH
CUSIP91324P10
Phone952-936-1300

Debt

Debt-to-Equity Ratio0.63
Current Ratio0.75
Quick Ratio0.75

Price-To-Earnings

Trailing P/E Ratio26.05
Forward P/E Ratio20.62
P/E Growth1.55

Sales & Book Value

Annual Sales$201.16 billion
Price / Sales1.26
Cash Flow$12.6485 per share
Price / Cash20.74
Book Value$51.42 per share
Price / Book5.10

Profitability

EPS (Most Recent Fiscal Year)$10.07
Net Income$10.56 billion
Net Margins5.55%
Return on Equity22.79%
Return on Assets7.65%

Miscellaneous

Employees260,000
Outstanding Shares962,470,000
Market Cap$250.59 billion

UnitedHealth Group (NYSE:UNH) Frequently Asked Questions

What is UnitedHealth Group's stock symbol?

UnitedHealth Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "UNH."

How often does UnitedHealth Group pay dividends? What is the dividend yield for UnitedHealth Group?

UnitedHealth Group announced a quarterly dividend on Wednesday, August 8th. Investors of record on Friday, September 7th will be paid a dividend of $0.90 per share on Tuesday, September 18th. This represents a $3.60 dividend on an annualized basis and a yield of 1.37%. The ex-dividend date of this dividend is Thursday, September 6th. View UnitedHealth Group's Dividend History.

How will UnitedHealth Group's stock buyback program work?

UnitedHealth Group declared that its board has authorized a share repurchase program on Wednesday, June 6th 2018, which allows the company to repurchase 100,000,000 shares, according to EventVestor. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company's management believes its shares are undervalued.

How were UnitedHealth Group's earnings last quarter?

UnitedHealth Group Inc (NYSE:UNH) announced its quarterly earnings results on Tuesday, July, 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, topping analysts' consensus estimates of $3.04 by $0.10. The healthcare conglomerate earned $56.09 billion during the quarter, compared to analysts' expectations of $56.10 billion. UnitedHealth Group had a net margin of 5.55% and a return on equity of 22.79%. UnitedHealth Group's revenue was up 12.1% on a year-over-year basis. During the same period in the previous year, the firm posted $2.46 earnings per share. View UnitedHealth Group's Earnings History.

When is UnitedHealth Group's next earnings date?

UnitedHealth Group is scheduled to release their next quarterly earnings announcement on Tuesday, October, 16th 2018. View Earnings Estimates for UnitedHealth Group.

What guidance has UnitedHealth Group issued on next quarter's earnings?

UnitedHealth Group issued an update on its FY18 earnings guidance on Tuesday, July, 17th. The company provided EPS guidance of $12.50-12.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $12.63.

What price target have analysts set for UNH?

20 brokerages have issued 12-month price targets for UnitedHealth Group's shares. Their predictions range from $240.00 to $300.00. On average, they anticipate UnitedHealth Group's share price to reach $270.35 in the next twelve months. This suggests a possible upside of 3.1% from the stock's current price. View Analyst Price Targets for UnitedHealth Group.

What is the consensus analysts' recommendation for UnitedHealth Group?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last year. There are currently 20 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for UnitedHealth Group.

What are Wall Street analysts saying about UnitedHealth Group stock?

Here are some recent quotes from research analysts about UnitedHealth Group stock:
  • 1. Cantor Fitzgerald analysts commented, "We rate the shares of UnitedHealth Group (UNH) Overweight. Our 12-month DCF-based price target is $300. The company is nicely diversified within its UnitedHealthcare (UHC) health insurance segment. The reduction in losses relating to individual exchange plans should help UNH post solid bottom-line growth in 2018. UNH is unique within our coverage universe given its Optum segment, which accounted for 44% of consolidated operating profit in 2017. We expect continued strong growth in Optum in 2018. We continue to believe that UNH should be a core holding in all large-cap growth portfolios." (8/9/2018)
  • 2. According to Zacks Investment Research, "Shares of UnitedHealth Group have outperformed the industry year to date. The company's robust Government business and continued strong performance at Optum are driving long-term growth. Its international business and strong capital position driving business investment are the other positives. The company has been witnessing an increase in membership over the past many years. It again lifted its 2018 earnings guidance, buoying optimism among investors in the stock. The company has witnessed its 2018 estimate increase by 1.2% to $12.62 over the past 90 days. However, membership loss in its fee-based commercial as well as Brazilian businesses will contract the overall membership growth for UnitedHealth Group. Additionally, higher medical care ratio raises concern." (7/15/2018)

Who are some of UnitedHealth Group's key competitors?

Who are UnitedHealth Group's key executives?

UnitedHealth Group's management team includes the folowing people:
  • Mr. Stephen J. Hemsley, Exec. Chairman (Age 65)
  • Mr. David Scott Wichmann, CEO & Director (Age 55)
  • Mr. Larry Chester Renfro, Office of the Chief Exec. & Vice Chairman (Age 64)
  • Mr. John F. Rex, Exec. VP & CFO (Age 56)
  • Ms. Marianne D. Short, Office of the Chief Exec., Exec. VP & Chief Legal Officer (Age 66)

Has UnitedHealth Group been receiving favorable news coverage?

Media stories about UNH stock have been trending positive on Saturday, according to Accern. The research firm scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. UnitedHealth Group earned a daily sentiment score of 0.28 on Accern's scale. They also gave press coverage about the healthcare conglomerate an impact score of 47.35 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View Recent Headlines for UnitedHealth Group.

Who are UnitedHealth Group's major shareholders?

UnitedHealth Group's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.98%), FMR LLC (6.41%), Bank of New York Mellon Corp (1.09%), Wells Fargo & Company MN (0.80%), Jennison Associates LLC (0.69%) and Morgan Stanley (0.57%). Company insiders that own UnitedHealth Group stock include D Ellen Wilson, Gail R Wilensky, Kenneth Irwin Shine, Larry C Renfro, Michele J Hooper, Richard T Burke, Steven H Nelson, Thomas E Roos and William C Ballard Jr. View Institutional Ownership Trends for UnitedHealth Group.

Which major investors are selling UnitedHealth Group stock?

UNH stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, United Services Automobile Association, Russell Investments Group Ltd., Putnam Investments LLC, Caisse DE Depot ET Placement DU Quebec, BlackRock Inc., Legal & General Group Plc and Schroder Investment Management Group. Company insiders that have sold UnitedHealth Group company stock in the last year include Gail R Wilensky, Kenneth Irwin Shine, Larry C Renfro, Michele J Hooper, Richard T Burke, Steven H Nelson, Thomas E Roos and William C Ballard Jr. View Insider Buying and Selling for UnitedHealth Group.

Which major investors are buying UnitedHealth Group stock?

UNH stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Vontobel Asset Management Inc., Bank of Montreal Can, Janus Henderson Group PLC, Chevy Chase Trust Holdings Inc., Fred Alger Management Inc., Jennison Associates LLC and Egerton Capital UK LLP. View Insider Buying and Selling for UnitedHealth Group.

How do I buy shares of UnitedHealth Group?

Shares of UNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is UnitedHealth Group's stock price today?

One share of UNH stock can currently be purchased for approximately $262.33.

How big of a company is UnitedHealth Group?

UnitedHealth Group has a market capitalization of $250.59 billion and generates $201.16 billion in revenue each year. The healthcare conglomerate earns $10.56 billion in net income (profit) each year or $10.07 on an earnings per share basis. UnitedHealth Group employs 260,000 workers across the globe.

How can I contact UnitedHealth Group?

UnitedHealth Group's mailing address is 9900 BREN ROAD EAST, MINNEAPOLIS MN, 55343. The healthcare conglomerate can be reached via phone at 952-936-1300 or via email at [email protected]


MarketBeat Community Rating for UnitedHealth Group (NYSE UNH)

Community Ranking:  3.6 out of 5 (star star star)
Outperform Votes:  1,198 (Vote Outperform)
Underperform Votes:  478 (Vote Underperform)
Total Votes:  1,676
MarketBeat's community ratings are surveys of what our community members think about UnitedHealth Group and other stocks. Vote "Outperform" if you believe UNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.